vTv Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-0.98
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-15.2

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.50-2.04-2.81-3.60-4.17-2.34-9.93-3.51-2.03-1.18-1.83K-2.34
Price/Sales ratio
58.38108.5972.72200.192.6518.6313.6615.5625.22N/A17.472.65
Price/Book Value ratio
-0.18-0.72-0.50-0.38-0.39-1.05-1.09-6.39-4.74-0.97-3.26-1.05
Price/Cash Flow ratio
-2.93-1.52-0.95-1.30-1.22-2.23-4.87-3.22-3.17-1.25-2.19K-2.23
Price/Free Cash Flow ratio
-2.93-1.52-0.95-1.30-1.22-2.23-4.87-3.22-3.17-1.25-2.18K-2.23
Price/Earnings Growth ratio
0.090.080.051.300.06-0.160.13-0.06-0.130.040.060.06
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-1109.10%-5600.19%-7115.77%-13521.99%-85.25%-446.99%-71.73%97.77%95.44%N/AN/A-85.25%
Operating Profit Margin
-1865.52%-7349.13%-8678.23%-17416.49%-159.43%-755.86%-184.78%-540.87%-1116.94%N/A-605.77%-755.86%
Pretax Profit Margin
-2330.60%-7920.42%-8730.75%-18504.12%-190.16%-790.08%-199.59%-439.85%-1232.55%N/A-1.23%-190.16%
Net Profit Margin
-2330.60%-5298.26%-2579.17%-5547.76%-63.62%-793.70%-137.62%-442.72%-1242.46%N/A-0.95%-63.62%
Effective Tax Rate
-13.52%34.32%70.45%-1.48%-0.84%-0.45%31.04%-0.65%-0.80%N/A-0.80%-0.84%
Return on Assets
-278.75%-30.04%-30.00%-57.82%-92.42%-236.75%-59.68%-69.60%-75.43%-183.79%-0.05%-92.42%
Return On Equity
7.23%35.26%17.98%10.68%9.54%44.75%11.01%182.04%233.45%82.05%0.17%44.75%
Return on Capital Employed
-474.73%-45.51%-127.77%-5129.75%192.87%507.70%-141.11%-127.60%-88.28%-6391.47%-47.66%507.70%
Liquidity Ratios
Current Ratio
N/A11.544.550.750.180.211.12N/AN/AN/A3.510.18
Quick Ratio
0.2311.544.550.750.180.191.071.823.511.001.590.18
Cash ratio
0.2011.394.500.430.080.130.891.571.570.881.570.08
Days of Sales Outstanding
N/A48.52N/A10.03KN/A0.668.995.192.24KN/A31.4331.43
Days of Inventory outstanding
N/AN/AN/A1.49N/A6.0312.29410.1159.51N/AN/A6.03
Operating Cycle
N/A48.52N/A10.03KN/A6.6921.28415.302.30KN/AN/A6.69
Days of Payables Outstanding
51.8351.1024.4120.8945.9353.8863.787.69K9.76K109.40N/A53.88
Cash Conversion Cycle
-51.83-2.57-24.4110.01K-45.93-47.18-42.50-7.27K-7.45KN/AN/A-45.93
Debt Ratios
Debt Ratio
2.79N/A0.200.701.830.670.010.010.010.030.820.82
Debt Equity Ratio
-0.07N/A-0.12-0.12-0.18-0.12-0.00-0.04-0.03-0.01-2.55-0.12
Long-term Debt to Capitalization
-0.07N/A-0.13-0.11-0.08N/AN/AN/AN/AN/A-0.03-0.08
Total Debt to Capitalization
-0.07N/A-0.13-0.14-0.23-0.14-0.00-0.04-0.03-0.01-0.07-0.23
Interest Coverage Ratio
N/A-21.98-138.24-16.39-6.02-11.43-0.01N/AN/AN/A-811.33K-11.43
Cash Flow to Debt Ratio
-0.85N/A-4.35-2.27-1.70-3.66-75.31-43.88-42.38-53.00-0.02-1.70
Company Equity Multiplier
-0.02-1.17-0.59-0.18-0.10-0.18-0.18-2.61-3.09-0.44-3.09-0.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-19.87-71.18-76.03-153.12-2.15-8.32-2.80-4.82-7.93N/A-0.00-2.15
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.001.00111.0011.001.00
Cash Flow Coverage Ratio
-0.85N/A-4.35-2.27-1.70-3.66-75.31-43.88-42.38-53.00-0.02-1.70
Short Term Coverage Ratio
-198.57N/AN/A-10.43-2.86-3.66-75.31-43.88-42.38-53.00-0.04-2.86
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A